SD Bahrs
University of Tübingen
16 Papers
58 Citations
SD Bahrs is an academic researcher from University of Tübingen. The author has contributed to research in topics: Breast MRI & Breast cancer. The author has an hindex of 8, co-authored 16 publications.
Chat about Author
Papers
Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: correlation with tumour response
Heike Preibsch,L Wanner,SD Bahrs,BM Wietek,KC Siegmann-Luz,E. Oberlecher,Markus Hahn,Annette Staebler,Konstantin Nikolaou,Benjamin Wiesinger +9 more
TL;DR: The reduction of BPE following neoadjuvant chemotherapy correlates with the tumour response, and the classification of the BPE shows good agreement among trained readers.
76
Breast MRI of pure ductal carcinoma in situ: sensitivity of diagnosis and influence of lesion characteristics.
Astrid Baur,SD Bahrs,Sina Speck,BM Wietek,Bernhard K. Krämer,Ulrich Vogel,Claus D. Claussen,KC Siegmann-Luz +7 more
TL;DR: MRI could detect pure DCIS more sensitively than Mx, and despite of missing statistically significance preoperative MRI seems to be helpful in patients with DCIS who are eligible for breast conservation.
45
Contrast-enhanced spectral mammography in patients with MRI contraindications.
Vivien Richter,Valerie Hatterman,Heike Preibsch,SD Bahrs,Markus Hahn,Konstantin Nikolaou,Benjamin Wiesinger +6 more
TL;DR: Contrastenhanced spectral mammography (CESM) is a novel breast imaging technique providing comparable diagnostic accuracy to breast magnetic resonance imaging (MRI) as discussed by the authors, which has been shown to outperform conventional mammography.
42
MR imaging-guided vacuum-assisted breast biopsy: Reduction of false-negative biopsies by short-term control MRI 24–48 h after biopsy
SD Bahrs,V Hattermann,Heike Preibsch,Markus Hahn,Annette Staebler,Claus D. Claussen,KC Siegmann-Luz +6 more
TL;DR: The rate of false-negative biopsies could be reduced to zero by using short-term follow-up MRI and a further CE breast MRI 24-48 h after benign MRI-VAB to eliminate missed cancers is recommended.
29
Management of breast lesions detectable only on MRI.
TL;DR: The indications, methods and results of MRI-guided interventions for the clarification of breast lesions only visible on MRI are described and alternative methods and pitfalls are presented.